The Effect of Propolis Extract from Sumatra, Indonesia on Escherichia coli and IL-6 Gene Expression in Male Wistar Rats Fed with a High-Fat Diet
DOI:
https://doi.org/10.26538/tjnpr/v8i6.3Keywords:
Interleukin-6, Escherichia coli, High-fat diet, PropolisAbstract
Propolis is a resinous substance produced by honey bees. It was collected from Sumatera, Indonesia, and its antibacterial properties against Escherichia coli and immunomodulatory effect on local intestinal inflammation was evaluated after ingestion of chow and high-fat diets. Male Wistar rats (Rattus norvegicus) were divided into four groups: chow diet (NCD), chow diet with propolis supplementation (NCDP), high-fat diet (HFD), and high-fat diet with propolis supplementation (HFDP) groups. The diets and propolis were administered according to the group assignment for 12 weeks. Faecal samples of the mice were collected at weeks 0, 4, and 12 and subjected to Escherichia coli quantitative real-time polymerase chain reaction (qRT-PCR). Further, reverse transcription-PCR (RT-PCR) analysis was performed using intestinal samples to analyze the interleukin-6 (IL-6) levels. In the NCDP group, E. coli gene expression decreased significantly at week 4 (p < 0.005) and remained low at week 12, whereas in the HFDP group, a significant decrease was observed in week 12. Meanwhile, in obese rats treated with propolis, the expression of the IL-6 gene was found to be high, although not statistically significant (p > 0.005). This study demonstrated the antibacterial effect of propolis against E. coli in normal and obese rats and indicated that propolis supplementation might exert an immunomodulatory effect in obese rats.
References
Przybyłek I, Karpí TM, Majtan J. Antibacterial properties of propolis. Molecules. 2019; Available from: www.mdpi.com/journal/molecules
Almuhayawi MS. Propolis as a novel antibacterial agent. Saudi J Biol Sci. Elsevier B.V. 2020;27:3079–86.
Irigoiti Y, Navarro A, Yamul D, Libonatti C, Tabera A, Basualdo M. The use of propolis as a functional food ingredient: A review. Trends Food Sci Technol. 2021;115:297–306.
Braakhuis A. Evidence on the health benefits of supplemental propolis. Nutrients. 2019;11. MDPI AG.
Magnavacca A, Sangiovanni E, Racagni G, Dell’agli M. The antiviral and immunomodulatory activities of propolis: An update and future perspectives for respiratory diseases. 2021; Available from: https://onlinelibrary.wiley.com/doi/10.1002/med.21866
Zulhendri F, Lesmana R, Tandean S, Christoper A, Chandrasekaran K, Irsyam I, Suwantika AA, Abdulah R, Wathoni N. Recent update on the anti-inflammatory activities of propolis. Molecules. 2022; Available from: https://doi.org/10.3390/molecules27238473
Hotamisligil GS. Inflammation, metaflammation and immunometabolic disorders. Nature [Internet]. 2017;542. Available from: http://www.metaflammation.org
Collins KH, Herzog W, MacDonald GZ, Reimer RA, Rios JL, Smith IC, Zernicke RF, Hart DA. Obesity, metabolic syndrome, and musculoskeletal disease: Common inflammatory pathways suggest a central role for loss of muscle integrity. Front Physiol|www.frontiersin.org [Internet]. 2018;9:112. Available from: www.frontiersin.org
Farkas GJ, Gorgey AS, Dolbow DR, Berg AS, Gater DR. Sex dimorphism in the distribution of adipose tissue and its influence on proinflammatory adipokines and cardiometabolic profiles in motor complete spinal cord injury. J Spinal Cord Med. 2019;42:430–6.
Kawai T, Autieri MV, Scalia R. Inflammation: From cellular mechanisms to immune cell education adipose tissue inflammation and metabolic dysfunction in obesity. 2021; Available from: www.ajpcell.org
Patimah I, Ellulu MS, Khaza’ai H, Rahmat A, Abed Y. State of the art paper obesity and inflammation: The linking mechanism and the complications. Arch Med Sci [Internet]. 2017;13:851–63. Available from: https://doi.org/10.5114/aoms.2016.58928
Sindhu S, Thomas R, Shihab P, Sriraman D, Behbehani K, Ahmad R. Obesity is a positive modulator of IL-6R and IL-6 expression in the subcutaneous adipose tissue: Significance for metabolic inflammation. PLoS One. 2015;10.
Bastías-Pérez M, Serra D, Herrero L. Dietary options for rodents in the study of obesity. Nutrients. MDPI AG; 2020;12:1–18.
de Moura E Dias M, Dos Reis SA, da Conceição LL, Sediyama CMNO, Pereira SS, de Oliveira LL, Gouveia Peluzio MDC, Martinez JA, Milagro FI. Diet-induced obesity in animal models: points to consider and influence on metabolic markers. Diabetol Metab Syndr. BioMed Central Ltd. 2021;13.
Malesza IJ, Malesza M, Walkowiak J, Mussin N, Walkowiak D, Aringazina R, Bartkowiak-Wieczorek J, Mądry E. High-fat, western-style diet, systemic 15.inflammation, and gut microbiota: A narrative review. 2021; Available from: https://doi.org/10.3390/cells10113164
Rohr MW, Narasimhulu CA, Rudeski-Rohr TA, Parthasarathy S. Negative effects of a high-fat diet on intestinal permeability: A review. Adv Nutr. Oxford University Press. 2020;11:77–91.
Barbier de La Serre C, Ellis CL, Lee J, Hartman AL, Rutledge JC, Raybould HE. Propensity to high-fat diet-
induced obesity in rats is associated with changes in the gut microbiota and gut inflammation. Am J Physiol Gastrointest Liver Physiol [Internet]. 2010;299:440–8. Available from: http://www.ajpgi.org
Mountford-McAuley R, Prior J, Clavijo McCormick A. Factors affecting propolis production. J Apicult Res. Taylor and Francis Ltd. 2023;62:162–70.
Mitchell SJ, Scheibye-Knudsen M, Longo DL, De Cabo R. Animal models of aging research: Implications for human aging and age-related diseases. Annu Rev Anim Biosci. 2015;3:283–303.
Hamdi D, Wijanarko A, Hermansyah H, Asih SC, Sahlan M. Production of Nanopropolis Using High-Pressure Ball Mill Homogenizer. In: IOP Conference Series: Earth and Environmental Science. Institute of Physics Publishing. 2019.
Mounieb F, Ramadan L, Akool ES, Balah A. Propolis alleviates concanavalin A-induced hepatitis by modulating cytokine secretion and inhibition of reactive oxygen species. Naunyn Schmiedebergs Arch Pharmacol. 2017;390:1105–15.
Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2-ΔΔCT method. Methods. 2001;25:402–8.
Meida NS, Purwanto B, Wasita B, Indrakila S, Soetrisno S, Poncorini E, Cilmiaty R, Pratiwi WR, Setyandriana Y, Almahira S. Effect of propolis extract on oxidative stress biomarker in diabetic Wistar rat (Rattus novergicus). Trop J Nat Prod Res. 2022;6:1193–6.
Sforcin JM. Biological Properties and Therapeutic Applications of Propolis. Vol. 30, Phytotherapy Research. John Wiley and Sons Ltd. 2016. p. 894–905.
Torres AR, Sandjo LP, Friedemann MT, Tomazzoli MM, Maraschin M, Mello CF, Santos ARS. Chemical characterization, antioxidant and antimicrobial activity of propolis obtained from Mlipona quadrifasciata and Tetragonisca angustula stingless bees. Braz J Med Biol Res. 2018;51.
Xue M, Liu Y, Xu H, Zhou Z, Ma Y, Sun T, Liu M, Zhang H, Liang H. Propolis modulates the gut microbiota and improves the intestinal mucosal barrier function in diabetic rats. Biomed Pharmacother. 2019;118.
Dalenberg H, Maes P, Mott B, Anderson KE, Spivak M. Propolis envelope promotes beneficial bacteria in the honey bee (Apis mellifera) mouthpart microbiome. Insects. 2020;11:1–12.
Saddiq AA, Danial EN. Effect of propolis as a food additive on the growth rate of the beneficial bacteria. Main Group Chem. 2014;13:223–32.
Okamura T, Hamaguchi M, Bamba R, Nakajima H, Yoshimura Y, Kimura T, Hashimoto Y, Majima S, Senmaru T, Ushigome E, Nakanishi N, Asano M, Yamazaki M, Nishimoto Y, Yamada T, Fujikura C, Asama T, Okumura N, Takakuwa H, Sasano R, Fukui M. Brazilian green propolis improves gut microbiota dysbiosis and protects against sarcopenic obesity. J Cachexia Sarcopenia Muscle. 2022;13:3028–47.
Gao W, Pu L, Wei J, Yao Z, Wang Y, Shi T, Zhao L, Jiao C, Changjiang Guo C. Serum antioxidant parameters are significantly increased in patients with type 2 diabetes mellitus after consumption of Chinese propolis: A randomized controlled trial based on fasting serum glucose level. Diabetes Therapy. 2018;9:101–11.
Scheller J, Chalaris A, Schmidt-Arras D, Rose-John S. The pro- and anti-inflammatory properties of the cytokine interleukin-6. Biochim Biophys Acta - Mol Cell Res. 2011;1813:878–88.
Guo Y, Wang B, Wang T, Gao L, Yang ZJ, Wang FF, Shang HW, Hua R, Xu JD. Biological characteristics of il-6 and related intestinal diseases. Int J Biol Sci. 2020;17:204–19.
Tanaka T, Narazaki M, Kishimoto T. Il-6 in inflammation, immunity, and disease. Cold Spring Harb Perspect Biol. 2014;6.
Published
How to Cite
Issue
Section
License
Copyright (c) 2024 Tropical Journal of Natural Product Research (TJNPR)
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
